SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001144204-10-027200
Filing Date
2010-05-14
Accepted
2010-05-14 11:45:30
Documents
5
Period of Report
2009-06-30

Document Format Files

Seq Description Document Type Size
1 v184709_10ka.htm 10-K/A 1708255
2 v184709_ex31-1.htm EX-31.1 9797
3 v184709_ex31-2.htm EX-31.2 10179
4 v184709_ex32-1.htm EX-32.1 6517
5 v184709_ex32-2.htm EX-32.2 7938
  Complete submission text file 0001144204-10-027200.txt   1744584
Mailing Address MIDDLE SECTION, LONGMAO STREET, AREA A LAIYANG WAIXIANGXING INDUSTRIAL PARK LAIYANG CITY, YANTAI, SHANDONG F4 710075
Business Address MIDDLE SECTION, LONGMAO STREET, AREA A LAIYANG WAIXIANGXING INDUSTRIAL PARK LAIYANG CITY, YANTAI, SHANDONG F4 710075 5619889880
Jiangbo Pharmaceuticals, Inc. (Filer) CIK: 0001091164 (see all company filings)

IRS No.: 651130026 | State of Incorp.: FL | Fiscal Year End: 0930
Type: 10-K/A | Act: 34 | File No.: 000-53037 | Film No.: 10831520
SIC: 2834 Pharmaceutical Preparations